Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 01, 2021, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Nitrofurantoin Capsules, USP (Macrocrystals), 25 mg, 50 mg and 100 mg.".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 01, 2021, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Nitrofurantoin Capsules, USP (Macrocrystals), 25 mg, 50 mg and 100 mg.".